2015-2027 Global Castleman Disease Treatment Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 134 pages | ID: 217F068A3DA6EN
Maia Research

Abstracts

The worldwide market for Castleman Disease Treatment is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
F.Hoffmann-La Roche
Hospira
Incyte
Merck
Bristol-Myers Squibb
Johnson & Johnson
Novartis
Pfizer

Major Types Covered
Monoclonal Antibodies
Chemotherapy
Radiation Therapy
Immunotherapy
Corticosteroids
Antiviral Drugs

Major Applications Covered
Hospitals
Clinical
Ambulatory Care Units

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Castleman Disease Treatment Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Castleman Disease Treatment Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE CASTLEMAN DISEASE TREATMENT MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL CASTLEMAN DISEASE TREATMENT MARKET-SEGMENTATION BY TYPE

5.1 Monoclonal Antibodies
5.2 Chemotherapy
5.3 Radiation Therapy
5.4 Immunotherapy
5.5 Corticosteroids
5.6 Antiviral Drugs

6 GLOBAL CASTLEMAN DISEASE TREATMENT MARKET-SEGMENTATION BY APPLICATION

6.1 Hospitals
6.2 Clinical
6.3 Ambulatory Care Units

7 GLOBAL CASTLEMAN DISEASE TREATMENT MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 F.Hoffmann-La Roche
  8.1.1 F.Hoffmann-La Roche Profile
  8.1.2 F.Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 F.Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis
  8.1.4 F.Hoffmann-La Roche Business Overview/Recent Development/Acquisitions
8.2 Hospira
  8.2.1 Hospira Profile
  8.2.2 Hospira Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Hospira Product/Solution Launches and Enhancements Analysis
  8.2.4 Hospira Business Overview/Recent Development/Acquisitions
8.3 Incyte
  8.3.1 Incyte Profile
  8.3.2 Incyte Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Incyte Product/Solution Launches and Enhancements Analysis
  8.3.4 Incyte Business Overview/Recent Development/Acquisitions
8.4 Merck
  8.4.1 Merck Profile
  8.4.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Merck Product/Solution Launches and Enhancements Analysis
  8.4.4 Merck Business Overview/Recent Development/Acquisitions
8.5 Bristol-Myers Squibb
  8.5.1 Bristol-Myers Squibb Profile
  8.5.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.5.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.6 Johnson & Johnson
  8.6.1 Johnson & Johnson Profile
  8.6.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.6.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.7 Novartis
  8.7.1 Novartis Profile
  8.7.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.7.4 Novartis Business Overview/Recent Development/Acquisitions
8.8 Pfizer
  8.8.1 Pfizer Profile
  8.8.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.8.4 Pfizer Business Overview/Recent Development/Acquisitions

9 GLOBAL CASTLEMAN DISEASE TREATMENT MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Castleman Disease Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Castleman Disease Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Castleman Disease Treatment Production Analysis from 2015-2020
10.4 North America Castleman Disease Treatment Consumption Analysis from 2015-2020
10.5 North America Castleman Disease Treatment Import and Export from 2015-2020
10.6 North America Castleman Disease Treatment Value, Production and Market Share by Type (2015-2020)
10.7 North America Castleman Disease Treatment Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Castleman Disease Treatment by Country (United States, Canada)
  10.8.1 North America Castleman Disease Treatment Sales by Country (2015-2020)
  10.8.2 North America Castleman Disease Treatment Consumption Value by Country (2015-2020)
10.9 North America Castleman Disease Treatment Market PEST Analysis

11 EUROPE

11.1 Europe Castleman Disease Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Castleman Disease Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Castleman Disease Treatment Production Analysis from 2015-2020
11.4 Europe Castleman Disease Treatment Consumption Analysis from 2015-2020
11.5 Europe Castleman Disease Treatment Import and Export from 2015-2020
11.6 Europe Castleman Disease Treatment Value, Production and Market Share by Type (2015-2020)
11.7 Europe Castleman Disease Treatment Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Castleman Disease Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Castleman Disease Treatment Sales by Country (2015-2020)
  11.8.2 Europe Castleman Disease Treatment Consumption Value by Country (2015-2020)
11.9 Europe Castleman Disease Treatment Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Castleman Disease Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Castleman Disease Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Castleman Disease Treatment Production Analysis from 2015-2020
12.4 Asia-Pacific Castleman Disease Treatment Consumption Analysis from 2015-2020
12.5 Asia-Pacific Castleman Disease Treatment Import and Export from 2015-2020
12.6 Asia-Pacific Castleman Disease Treatment Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Castleman Disease Treatment Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Castleman Disease Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Castleman Disease Treatment Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Castleman Disease Treatment Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Castleman Disease Treatment Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Castleman Disease Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Castleman Disease Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Castleman Disease Treatment Production Analysis from 2015-2020
13.4 Latin America Castleman Disease Treatment Consumption Analysis from 2015-2020
13.5 Latin America Castleman Disease Treatment Import and Export from 2015-2020
13.6 Latin America Castleman Disease Treatment Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Castleman Disease Treatment Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Castleman Disease Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Castleman Disease Treatment Sales by Country (2015-2020)
  13.8.2 Latin America Castleman Disease Treatment Consumption Value by Country (2015-2020)
13.9 Latin America Castleman Disease Treatment Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Castleman Disease Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Castleman Disease Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Castleman Disease Treatment Production Analysis from 2015-2020
14.4 Middle East & Africa Castleman Disease Treatment Consumption Analysis from 2015-2020
14.5 Middle East & Africa Castleman Disease Treatment Import and Export from 2015-2020
14.6 Middle East & Africa Castleman Disease Treatment Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Castleman Disease Treatment Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Castleman Disease Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Castleman Disease Treatment Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Castleman Disease Treatment Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Castleman Disease Treatment Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL CASTLEMAN DISEASE TREATMENT MARKET FROM 2020-2027

15.1 Future Forecast of the Global Castleman Disease Treatment Market from 2020-2027 Segment by Region
15.2 Global Castleman Disease Treatment Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Castleman Disease Treatment Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Castleman Disease Treatment Market Value ($) and Growth Rate of Castleman Disease Treatment from 2015-2027
Global Castleman Disease Treatment Production and Growth Rate Segment by Product Type from 2015-2027
Global Castleman Disease Treatment Consumption and Growth Rate Segment by Application from 2015-2027
Figure Castleman Disease Treatment Picture
Table Product Specifications of Castleman Disease Treatment
Table Driving Factors for this Market
Table Industry News of Castleman Disease Treatment Market
Figure Value Chain Status of Castleman Disease Treatment
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Castleman Disease Treatment Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Castleman Disease Treatment Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Monoclonal Antibodies of Castleman Disease Treatment
Figure Chemotherapy of Castleman Disease Treatment
Figure Radiation Therapy of Castleman Disease Treatment
Figure Immunotherapy of Castleman Disease Treatment
Figure Corticosteroids of Castleman Disease Treatment
Figure Antiviral Drugs of Castleman Disease Treatment
Table Global Castleman Disease Treatment Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Castleman Disease Treatment Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospitals of Castleman Disease Treatment
Figure Clinical of Castleman Disease Treatment
Figure Ambulatory Care Units of Castleman Disease Treatment
Table Global Castleman Disease Treatment Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Castleman Disease Treatment Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Castleman Disease Treatment
Figure Online Channel of Castleman Disease Treatment
Table F.Hoffmann-La Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure F.Hoffmann-La Roche Sales and Growth Rate from 2015-2020
Figure F.Hoffmann-La Roche Revenue ($) and Global Market Share from 2015-2020
Table F.Hoffmann-La Roche Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Hospira Profile (Company Name, Plants Distribution, Sales Region)
Figure Hospira Sales and Growth Rate from 2015-2020
Figure Hospira Revenue ($) and Global Market Share from 2015-2020
Table Hospira Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Incyte Profile (Company Name, Plants Distribution, Sales Region)
Figure Incyte Sales and Growth Rate from 2015-2020
Figure Incyte Revenue ($) and Global Market Share from 2015-2020
Table Incyte Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Castleman Disease Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Castleman Disease Treatment Production Value ($) by Region from 2015-2020
Table Global Castleman Disease Treatment Production Value Share by Region from 2015-2020
Table Global Castleman Disease Treatment Production by Region from 2015-2020
Table Global Castleman Disease Treatment Consumption Value ($) by Region from 2015-2020
Table Global Castleman Disease Treatment Consumption by Region from 2015-2020
Table North America Castleman Disease Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Castleman Disease Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Castleman Disease Treatment Import and Export from 2015-2020
Table North America Castleman Disease Treatment Value ($) by Type (2015-2020)
Table North America Castleman Disease Treatment Production by Type (2015-2020)
Table North America Castleman Disease Treatment Consumption by Application (2015-2020)
Table North America Castleman Disease Treatment Consumption by Country (2015-2020)
Table North America Castleman Disease Treatment Consumption Value ($) by Country (2015-2020)
Figure North America Castleman Disease Treatment Market PEST Analysis
Table Europe Castleman Disease Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Castleman Disease Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Castleman Disease Treatment Import and Export from 2015-2020
Table Europe Castleman Disease Treatment Value ($) by Type (2015-2020)
Table Europe Castleman Disease Treatment Production by Type (2015-2020)
Table Europe Castleman Disease Treatment Consumption by Application (2015-2020)
Table Europe Castleman Disease Treatment Consumption by Country (2015-2020)
Table Europe Castleman Disease Treatment Consumption Value ($) by Country (2015-2020)
Figure Europe Castleman Disease Treatment Market PEST Analysis
Table Asia-Pacific Castleman Disease Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Castleman Disease Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Castleman Disease Treatment Import and Export from 2015-2020
Table Asia-Pacific Castleman Disease Treatment Value ($) by Type (2015-2020)
Table Asia-Pacific Castleman Disease Treatment Production by Type (2015-2020)
Table Asia-Pacific Castleman Disease Treatment Consumption by Application (2015-2020)
Table Asia-Pacific Castleman Disease Treatment Consumption by Country (2015-2020)
Table Asia-Pacific Castleman Disease Treatment Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Castleman Disease Treatment Market PEST Analysis
Table Latin America Castleman Disease Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Castleman Disease Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Castleman Disease Treatment Import and Export from 2015-2020
Table Latin America Castleman Disease Treatment Value ($) by Type (2015-2020)
Table Latin America Castleman Disease Treatment Production by Type (2015-2020)
Table Latin America Castleman Disease Treatment Consumption by Application (2015-2020)
Table Latin America Castleman Disease Treatment Consumption by Country (2015-2020)
Table Latin America Castleman Disease Treatment Consumption Value ($) by Country (2015-2020)
Figure Latin America Castleman Disease Treatment Market PEST Analysis
Table Middle East & Africa Castleman Disease Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Castleman Disease Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Castleman Disease Treatment Import and Export from 2015-2020
Table Middle East & Africa Castleman Disease Treatment Value ($) by Type (2015-2020)
Table Middle East & Africa Castleman Disease Treatment Production by Type (2015-2020)
Table Middle East & Africa Castleman Disease Treatment Consumption by Application (2015-2020)
Table Middle East & Africa Castleman Disease Treatment Consumption by Country (2015-2020)
Table Middle East & Africa Castleman Disease Treatment Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Castleman Disease Treatment Market PEST Analysis
Table Global Castleman Disease Treatment Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Castleman Disease Treatment Production and Growth Rate Forecast by Region (2020-2027)
Table Global Castleman Disease Treatment Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Castleman Disease Treatment Production and Growth Rate Forecast by Type (2020-2027)
Table Global Castleman Disease Treatment Consumption and Growth Rate Forecast by Application (2020-2027)